In summary, we could not detect mechanistic clues relating to a potential link between SF3B1 mutation and altered DDR responses, using isogenic cell lines and a treatment-naïve CLL cohort. This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.